Etiologically, the high incidence of double primary cancer (prostate cancer and BC) has been reported [3], which is supported by the biological findings that common molecular pathways, such as androgen receptor (AR) signaling, contributes to the carcinogenesis and tumorigenesis of prostate cancer as well as BC [4, 5]. The gene discussed is AR; the disease is prostate cancer.